Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion ...

Dry spells are common in many relationships, but if this is becoming a problem, you can get your groove back. Here are some tips to help keep that flame alive.

Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmac ...

Fintel reports that on March 14, 2025, Goldman Sachs initiated coverage of 89bio (NasdaqGM:ETNB) with a Neutral ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of 89bio (NasdaqGM:ETNB) with a Buy recommendation.

NAFLD, the most prevalent liver disease, affects approximately 25% of the global population (1.2 billion people), including 188 million in India. Left untreated, NAFLD can progress to non-alcoholic ...

A group of state lawmakers and a Macomb County official want stricter limits than the state proposes for Oakland County's ...

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) is expected to be releasing its earnings data before the market opens on ...

Identify the warning signs of hepatitis before they become serious. From subtle fatigue to more obvious symptoms, recognizing liver inflammation early can save.

The ENCORE-LF study of an-caspase inhibitor emricasan in NASH cirrhosis showed that the drug was unable to meet it treatment objective of improving event-free survival and the entire study is ...